Aferrix develops tools for the early diagnosis and monitoring of serum iron toxicity. The companys solutions include methods that quantify different forms of toxic iron not detected by conventional tests.

Aferrix offers iron testing services and kits for research and treatment centers specializing in iron overload diseases (e.g. thalassemia, hemochromatosis, and myelodysplastic syndrome) and for pharmaceutical companies that are developing iron chelators.

All of the companys products are CE marked for IVD use.